Hataphar
Hataphar operates in Pharmaceuticals.
Market Cap & Net Worth: Hataphar (DHT)
Hataphar (VN:DHT) has a market capitalization of $26.04K (₫661.50 Million) as of March 18, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #43467 globally and #322 in its home market, demonstrating a -0.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hataphar's stock price ₫69000.00 by its total outstanding shares 9587 (9.59K).
Hataphar Market Cap History: 2015 to 2026
Hataphar's market capitalization history from 2015 to 2026. Data shows growth from $1.10K to $26.04K (37.33% CAGR).
Index Memberships
Hataphar is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
HNX 30
HNX30
|
$342.80K | 7.16% | #3 of 30 |
|
HNX
HNXI
|
$1.88 Million | 1.31% | #11 of 302 |
|
HNX Large Cap
HNXLC
|
$441.93K | 5.56% | #4 of 49 |
Weight: Hataphar's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Hataphar Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hataphar's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DHT by Market Capitalization
Companies near Hataphar in the global market cap rankings as of March 18, 2026.
Key companies related to Hataphar by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3469 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #5585 globally with a market cap of $1.61 Billion USD ( ₩2.36 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7048 globally with a market cap of $1.07 Billion USD ( ₩1.56 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7477 globally with a market cap of $962.14 Million USD ( ₩1.41 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3469 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩730000.00 |
| #5585 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.61 Billion | ₩113500.00 |
| #7048 | ST Pharm Co.Ltd | KQ:237690 | $1.07 Billion | ₩155100.00 |
| #7477 | Oscotec Inc | KQ:039200 | $962.14 Million | ₩59300.00 |
Hataphar Historical Marketcap From 2015 to 2026
Between 2015 and today, Hataphar's market cap moved from $1.10K to $ 26.04K, with a yearly change of 37.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫26.04K | -1.43% |
| 2025 | ₫26.41K | -26.32% |
| 2024 | ₫35.85K | +324.67% |
| 2023 | ₫8.44K | +65.55% |
| 2022 | ₫5.10K | -9.25% |
| 2021 | ₫5.62K | -15.57% |
| 2020 | ₫6.65K | +14.02% |
| 2019 | ₫5.84K | +33.97% |
| 2018 | ₫4.36K | +0.83% |
| 2017 | ₫4.32K | +145.99% |
| 2016 | ₫1.76K | +60.07% |
| 2015 | ₫1.10K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Hataphar was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.04K USD |
| MoneyControl | $26.04K USD |
| MarketWatch | $26.04K USD |
| marketcap.company | $26.04K USD |
| Reuters | $26.04K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.